Disease/Infection News

RSS

Merck signs two licensing agreements for investigational HIV drug candidates

Merck, known as MSD outside the United States and Canada, announced today that the company has signed two licensing agreements for investigational HIV drug candidates.

25 Jul 2012

Little evidence exists for potential HPV type competition in cross-sectional study

Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18. Is there a chance that the increased number of people vaccinated might result in an increase of other types of HPV that cause cancer?

25 Jul 2012

Bill Gates stresses importance of investment in both HIV treatment and research for vaccines, microbicides

In a symposium session on Monday at the XIX International AIDS Conference in Washington, D.C., politicians and public health experts joined Bill & Melinda Gates Foundation Co-Chair Bill Gates for a discussion about improving effectiveness and efficiency in the HIV/AIDS response, the Washington Post reports.

25 Jul 2012

Researchers discover bats as reservoir of infections

Measles, mumps, pneumonia, influenza and encephalitis in man, Carré's disease in dogs, Ovine Rinderpest (PPR)… all of these diseases are caused by viruses from the same family: Paramyxoviridae. A vast international study, carried out in collaboration with IRD researchers and published in Nature communications has led to the discovery of more than 60 new species of these dangerous infectious agents, almost double the number previously recorded. This family of highly diverse pathogens affects all animals, from canines to fowl, cattle and humans.

25 Jul 2012

Secretary Clinton reaffirms U.S. commitment to 'AIDS-free generation,' pledges more than $150M for global efforts

In a speech delivered at the XIX International AIDS Conference in Washington, D.C., on Monday, U.S. Secretary of State Hillary Clinton "underscored the United States' commitment to achieving an 'AIDS-free generation' and announced more than $150 million in additional funding," Politico reports.

25 Jul 2012

Dapivirine Phase III trial now underway in Africa to treat HIV in women

A large clinical trial testing the long-term safety and effectiveness of a new approach for preventing HIV in women - a vaginal ring used once a month - is now underway in Africa, researchers announced today at the XIX International AIDS Conference (AIDS 2012).

25 Jul 2012

Views on AIDS: The benefits of male circumcision; A more optimistic battle; The need to focus on high-impact prevention strategies

A selection of editorials and op-eds from around the country that focus on the campaign to eradicate HIV.

25 Jul 2012

Insight into possible new approaches in vaccine development for blood-borne infections and HIV

White blood cells called neutrophils, which are the first line of defense against infection, play an unexpected role by boosting antibody production, according to research led by Mount Sinai School of Medicine. The findings suggest neutrophils have multiple roles within the immune system and function at levels previously unknown to the scientific community. The research, published in Nature Immunology, provides groundbreaking insight into possible new approaches in vaccine development for blood-borne infections and HIV.

25 Jul 2012

Scientists discover structure and operating procedures of anti-bacterial killing machine

Scientists have discovered the structure and operating procedures of a powerful anti-bacterial killing machine that could become an alternative to antibiotics.

25 Jul 2012

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Chimerix, Inc. today announced the execution of a license agreement granting Merck, known as MSD outside the United States and Canada, exclusive worldwide rights to CMX157, Chimerix's novel lipid acyclic nucleoside phosphonate currently being evaluated to treat HIV infection.

24 Jul 2012

Recent release: Examining next steps for corporate responsibility programs in India

In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Aarthi Rao, a program officer at the institute, examines whether corporate social responsibility (CSR) programs within Indian pharmaceutical companies can help fight neglected diseases.

24 Jul 2012

Recent release: World Bank discussion addresses AIDS spending in resource-constrained environment

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Mead Over, economist and senior fellow at CGD, previews his participation in a panel that took place Monday evening at the XIX International AIDS Conference.

24 Jul 2012

Recent release: CSIS blog posts highlight panel discussions on PEPFAR, examine challenges to administering treatment-as-prevention

"In advance of the XIX International AIDS Conference -- AIDS 2012 -- CSIS celebrated the release of the special supplement of the Journal of AIDS focused on PEPFAR" with an event organized in cooperation with the Office of the Global AIDS Coordinator (OGAC)," the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog reports.

24 Jul 2012

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."

24 Jul 2012

Most Indian female sex workers do not disclose HIV serostatus to sex partners

Researchers from Boston University School of Medicine (BUSM) in partnership with Indian researchers and HIV positive networks groups, have found that in India, non-disclosure of HIV serostatus to sex partners among both HIV-infected female sex workers (FSWs) and HIV-infected clients of FSWs is exceedingly common.

24 Jul 2012

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Today, U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg announced the agency has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Relief (PEPFAR) to treat those infected with HIV/AIDS in countries that lack the tools needed to fight the AIDS epidemic.

24 Jul 2012

Novel combination drug regimen could be more effective than existing treatments for TB

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet.

24 Jul 2012

International AIDS conference kicks off in Washington, D.C.

The XIX International AIDS Conference opened in Washington, D.C., on Sunday and "is expected to draw 25,000 people, including politicians, scientists and activists, as well as some of the estimated 34 million people living with HIV who will tell their stories," Agence France-Presse reports.

24 Jul 2012

First results from community HIV testing campaign in Uganda

A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.

24 Jul 2012

Sex workers hold AIDS 2012 'hub' conference in Kolkata, India

"Hundreds of sex workers from around the world who said they were denied visas to attend an international AIDS conference in the United States began their own meeting in Kolkata on Saturday in protest," Agence France-Presse reports.

24 Jul 2012

Disease/Infection News

Merck signs two licensing agreements for investigational HIV drug candidates

Little evidence exists for potential HPV type competition in cross-sectional study

Bill Gates stresses importance of investment in both HIV treatment and research for vaccines, microbicides

Researchers discover bats as reservoir of infections

Secretary Clinton reaffirms U.S. commitment to 'AIDS-free generation,' pledges more than $150M for global efforts

Dapivirine Phase III trial now underway in Africa to treat HIV in women

Views on AIDS: The benefits of male circumcision; A more optimistic battle; The need to focus on high-impact prevention strategies

Insight into possible new approaches in vaccine development for blood-borne infections and HIV

Scientists discover structure and operating procedures of anti-bacterial killing machine

Merck, Chimerix sign license agreement for CMX157 to treat HIV infection

Recent release: Examining next steps for corporate responsibility programs in India

Recent release: World Bank discussion addresses AIDS spending in resource-constrained environment

Recent release: CSIS blog posts highlight panel discussions on PEPFAR, examine challenges to administering treatment-as-prevention

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

Most Indian female sex workers do not disclose HIV serostatus to sex partners

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Novel combination drug regimen could be more effective than existing treatments for TB

International AIDS conference kicks off in Washington, D.C.

First results from community HIV testing campaign in Uganda

Sex workers hold AIDS 2012 'hub' conference in Kolkata, India

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News